共 50 条
- [41] Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus Arthritis Research & Therapy, 18
- [42] THE T-CELL RECEPTOR BETA-CHAIN AND SYSTEMIC LUPUS-ERYTHEMATOSUS CLINICAL RESEARCH, 1987, 35 (01): : A86 - A86
- [45] MODULATION OF IGM ANTI-LYMPYOCYTE ANTIBODY-REACTIVE T-CELL SURFACE-ANTIGENS IN SYSTEMIC LUPUS-ERYTHEMATOSUS JOURNAL OF IMMUNOLOGY, 1986, 136 (09): : 3246 - 3253
- [46] DEFECTIVE CD2 PATHWAY T-CELL ACTIVATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARTHRITIS AND RHEUMATISM, 1991, 34 (05): : 561 - 571
- [47] IMMUNOREGULATORY SUBPOPULATIONS OF LYMPHOCYTES-T IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS BEFORE AND AFTER HEMOSORPTION VRACHEBNOE DELO, 1987, (02): : 94 - 98
- [48] OKT4+ T-CELL DEFICIENCY AND AN ASSOCIATION OF IMMUNOGLOBULIN DEFICIENCY IN SYSTEMIC LUPUS-ERYTHEMATOSUS CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 72 (03): : 446 - 449
- [49] RELATIONSHIP OF ANTI-BETA-2-MICROGLOBULIN ANTIBODIES TO T11 AND T-CELL ACTIVATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1985, 37 (02): : 179 - 190
- [50] COMPARISON IN T-CELL AND B-CELL MARKERS IN PATIENTS WITH SJOGRENS SYNDROME AND SYSTEMIC LUPUS-ERYTHEMATOSUS CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 22 (02): : 270 - 278